Recent insider trading activity from Kanes Stephen, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Centessa Pharmaceuticals plc | $CNTA | Kanes Stephen | Chief Medical Officer | A | Ordinary Shares | 120000 | $0.00 | 120,000.0000 | 134,447,836 | 9999.99% | 0.09% |
| Feb. 3, 2025 | Centessa Pharmaceuticals plc | $CNTA | Kanes Stephen | Chief Medical Officer | A | Share Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |